SOMATROPIN

SOMATROPIN was reported 74878 times

These side effects are most commonly reported by patients taking SOMATROPIN:

# Side effect Count
0 DRUG DOSE OMISSION BY DEVICE 19220
1 DEVICE LEAKAGE 11126
2 DEVICE BREAKAGE 9710
3 DEVICE MECHANICAL ISSUE 8152
4 DEVICE INFORMATION OUTPUT ISSUE 7077
5 DEVICE ISSUE 5869
6 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 5061
7 INJECTION SITE PAIN 3770
8 DEVICE USE ERROR 3445
9 POOR QUALITY DEVICE USED 3210
10 DEVICE PHYSICAL PROPERTY ISSUE 3050
11 INCORRECT DOSE ADMINISTERED BY DEVICE 2875
12 DEVICE USE ISSUE 2834
13 INCORRECT DOSE ADMINISTERED 2831
14 DEVICE DELIVERY SYSTEM ISSUE 2532
15 DEVICE MALFUNCTION 2429
16 DEVICE DEFECTIVE 2335
17 HEADACHE 2239
18 OFF LABEL USE 2049
19 PRODUCT DOSE OMISSION ISSUE 1927
20 DEVICE POWER SOURCE ISSUE 1635
21 DEVICE DIFFICULT TO USE 1473
22 EXPIRED DEVICE USED 1463
23 FATIGUE 1299
24 PRODUCT PRESCRIBING ERROR 1221
25 DEVICE FAILURE 1178
26 INJECTION SITE HAEMORRHAGE 1138
27 DRUG INEFFECTIVE 1137
28 INJECTION SITE BRUISING 1119
29 MALAISE 1078
30 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1076
31 NEEDLE ISSUE 1054
32 ACCIDENTAL EXPOSURE TO PRODUCT 1006
33 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 968
34 ARTHRALGIA 959
35 DRUG DOSE OMISSION 902
36 PRODUCT STORAGE ERROR 875
37 DEATH 874
38 DEVICE OCCLUSION 863
39 EXPOSURE VIA SKIN CONTACT 798
40 LIQUID PRODUCT PHYSICAL ISSUE 792
41 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 791
42 DEVICE MATERIAL ISSUE 791
43 VOMITING 787
44 PAIN 777
45 PYREXIA 763
46 PRODUCT DOSE OMISSION 759
47 PAIN IN EXTREMITY 683
48 WEIGHT INCREASED 673
49 NAUSEA 630
50 UNDERDOSE 587
51 ASTHENIA 566
52 DIZZINESS 528
53 PRODUCT USE IN UNAPPROVED INDICATION 528
54 WEIGHT DECREASED 489
55 PRODUCT COMMUNICATION ISSUE 444
56 SEIZURE 444
57 FALL 422
58 CONDITION AGGRAVATED 416
59 BLOOD GLUCOSE INCREASED 413
60 ANXIETY 407
61 PNEUMONIA 401
62 DIARRHOEA 398
63 FEELING ABNORMAL 393
64 INSULIN-LIKE GROWTH FACTOR INCREASED 390
65 INSOMNIA 378
66 RASH 378
67 DRUG ADMINISTERED IN WRONG DEVICE 368
68 INJECTION SITE DISCHARGE 354
69 NASOPHARYNGITIS 346
70 SOMNOLENCE 316
71 BRAIN NEOPLASM 315
72 HOSPITALISATION 311
73 DYSPNOEA 309
74 PRODUCT QUALITY ISSUE 303
75 INTENTIONAL PRODUCT MISUSE 294
76 PERIPHERAL SWELLING 293
77 DEPRESSION 288
78 PRODUCT USE ISSUE 285
79 BACK PAIN 282
80 THERAPY INTERRUPTED 280
81 ABDOMINAL PAIN UPPER 277
82 HYPERSENSITIVITY 276
83 CONTUSION 275
84 SLEEP APNOEA SYNDROME 275
85 DECREASED APPETITE 272
86 INFLUENZA 269
87 ABDOMINAL PAIN 265
88 SCOLIOSIS 260
89 COUGH 259
90 COVID-19 257
91 PRODUCT AVAILABILITY ISSUE 257
92 MEMORY IMPAIRMENT 255
93 OVERDOSE 252
94 GROWTH RETARDATION 251
95 POOR QUALITY PRODUCT ADMINISTERED 247
96 ILLNESS 246
97 CEREBROVASCULAR ACCIDENT 236
98 HYPERTENSION 234
99 INJURY ASSOCIATED WITH DEVICE 232
100 MYALGIA 231
101 MIGRAINE 227
102 PRODUCT PREPARATION ISSUE 226
103 INJECTION SITE EXTRAVASATION 224
104 INJECTION SITE MASS 224
105 INJECTION SITE ERYTHEMA 222
106 CRYING 218
107 INSULIN-LIKE GROWTH FACTOR DECREASED 216
108 VISUAL IMPAIRMENT 213
109 GAIT DISTURBANCE 212
110 HYPOGLYCAEMIA 209
111 SYNCOPE 207
112 URTICARIA 206
113 NEOPLASM RECURRENCE 201
114 FEAR OF INJECTION 200
115 INJECTION SITE DISCOMFORT 198
116 THERAPY CESSATION 198
117 DEVICE DEPLOYMENT ISSUE 195
118 CONSTIPATION 194
119 ACCIDENTAL OVERDOSE 191
120 LOSS OF CONSCIOUSNESS 191
121 INJECTION SITE SWELLING 190
122 PRODUCT PREPARATION ERROR 190
123 CRANIOPHARYNGIOMA 185
124 MEDICATION ERROR 183
125 OEDEMA PERIPHERAL 183
126 AGGRESSION 182
127 DEVICE OPERATIONAL ISSUE 180
128 VIRAL INFECTION 177
129 WRONG DEVICE USED 175
130 NO ADVERSE EVENT 174
131 ABNORMAL BEHAVIOUR 173
132 PRODUCT DISPENSING ERROR 172
133 INFECTION 171
134 TREMOR 171
135 CHEST PAIN 170
136 PRODUCT RECONSTITUTION QUALITY ISSUE 170
137 EPILEPSY 169
138 HYPERHIDROSIS 168
139 PRURITUS 168
140 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 163
141 DEHYDRATION 162
142 DIABETES MELLITUS 161
143 INTENTIONAL PRODUCT USE ISSUE 159
144 PITUITARY TUMOUR BENIGN 159
145 IRRITABILITY 157
146 HYPOAESTHESIA 156
147 BLOOD GLUCOSE DECREASED 153
148 ALOPECIA 152
149 INTENTIONAL DOSE OMISSION 150
150 DEVICE CONNECTION ISSUE 149
151 PRODUCT PHYSICAL ISSUE 147
152 CONVULSION 145
153 FLUID RETENTION 145
154 JOINT SWELLING 145
155 VISION BLURRED 145
156 MUSCLE SPASMS 142
157 URINARY TRACT INFECTION 142
158 DEVICE DISPENSING ERROR 140
159 INTRACRANIAL PRESSURE INCREASED 139
160 DRUG HYPERSENSITIVITY 138
161 PRODUCT ODOUR ABNORMAL 138
162 BLOOD ALKALINE PHOSPHATASE INCREASED 137
163 MOOD ALTERED 137
164 STRESS 137
165 ASTHMA 136
166 SINUSITIS 136
167 SLEEP DISORDER 136
168 BONE PAIN 134
169 PARAESTHESIA 134
170 CARDIAC DISORDER 133
171 INJECTION SITE REACTION 133
172 LETHARGY 133
173 DISEASE RECURRENCE 132
174 MULTIPLE USE OF SINGLE-USE PRODUCT 132
175 PRODUCT PACKAGING QUANTITY ISSUE 132
176 PALPITATIONS 131
177 THERAPEUTIC RESPONSE UNEXPECTED 131
178 ABDOMINAL DISCOMFORT 130
179 PRODUCT KNOWLEDGE DEFICIT 129
180 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 128
181 OROPHARYNGEAL PAIN 128
182 NEOPLASM MALIGNANT 127
183 PITUITARY TUMOUR 127
184 BURNING SENSATION 126
185 CONFUSIONAL STATE 126
186 NERVOUSNESS 126
187 INTENTIONAL DEVICE MISUSE 124
188 DRUG INTERACTION 123
189 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 123
190 DRUG ABUSE 122
191 ANAEMIA 121
192 INCREASED APPETITE 121
193 SWELLING 121
194 ARTHROPATHY 120
195 PRODUCT ADMINISTRATION ERROR 120
196 EAR INFECTION 118
197 BLOOD CHOLESTEROL INCREASED 117
198 HYPOTHYROIDISM 117
199 SWELLING FACE 117
200 BLOOD PRESSURE INCREASED 116
201 SURGERY 116
202 HEART RATE INCREASED 115
203 DEVICE ELECTRICAL FINDING 114
204 GLYCOSYLATED HAEMOGLOBIN INCREASED 114
205 HAEMORRHAGE 112
206 ACNE 111
207 MYOCARDIAL INFARCTION 111
208 PAPILLOEDEMA 111
209 PRODUCT SOLUBILITY ABNORMAL 109
210 PHARMACEUTICAL PRODUCT COMPLAINT 108
211 MUSCULAR WEAKNESS 107
212 ADRENOCORTICAL INSUFFICIENCY ACUTE 105
213 ALANINE AMINOTRANSFERASE INCREASED 105
214 BLOOD TRIGLYCERIDES INCREASED 105
215 OSTEOCHONDROSIS 105
216 SNORING 102
217 ANGER 101
218 RENAL FAILURE 101
219 EPISTAXIS 100
220 PRODUCT USE COMPLAINT 100
221 INJECTION SITE PRURITUS 99
222 NEOPLASM 99
223 TREATMENT NONCOMPLIANCE 99
224 NECK PAIN 98
225 ERYTHEMA 97
226 EXPIRED PRODUCT ADMINISTERED 97
227 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 97
228 NEOPLASM PROGRESSION 96
229 SEPSIS 96
230 BLINDNESS 95
231 GENERAL PHYSICAL HEALTH DETERIORATION 94
232 MENTAL DISORDER 94
233 BLOOD THYROID STIMULATING HORMONE DECREASED 93
234 DRY SKIN 93
235 HYPERSOMNIA 93
236 OEDEMA 93
237 OSTEONECROSIS 93
238 ROAD TRAFFIC ACCIDENT 93
239 SUSPECTED OFF LABEL USE 93
240 UPPER LIMB FRACTURE 93
241 DEPRESSED MOOD 92
242 SYRINGE ISSUE 92
243 ABDOMINAL DISTENSION 91
244 HYPOTENSION 91
245 RENAL DISORDER 91
246 EPIPHYSIOLYSIS 90
247 GASTROINTESTINAL DISORDER 89
248 HYPOTHALAMO-PITUITARY DISORDER 89
249 RHINORRHOEA 89
250 TACHYCARDIA 89
251 VITAMIN D DECREASED 89
252 INJECTION SITE RASH 88
253 PRODUCT DOSE OMISSION IN ERROR 88
254 AGITATION 87
255 DISCOMFORT 87
256 DISTURBANCE IN ATTENTION 87
257 GASTROENTERITIS VIRAL 87
258 INCORRECT DOSAGE ADMINISTERED 87
259 LOWER RESPIRATORY TRACT INFECTION 87
260 BLOOD CREATININE DECREASED 86
261 CARPAL TUNNEL SYNDROME 86
262 GASTROENTERITIS 86
263 ASPARTATE AMINOTRANSFERASE INCREASED 85
264 INFLUENZA LIKE ILLNESS 85
265 ARTHRITIS 82
266 PRESCRIBED OVERDOSE 82
267 EMOTIONAL DISORDER 81
268 FEELING HOT 80
269 AMNESIA 79
270 HAEMOGLOBIN DECREASED 79
271 BRONCHITIS 78
272 HORMONE LEVEL ABNORMAL 78
273 MENINGIOMA 78
274 MUSCULOSKELETAL STIFFNESS 78
275 PRODUCT DEPOSIT 78
276 ADENOIDAL HYPERTROPHY 77
277 LOWER LIMB FRACTURE 77
278 PRODUCT LEAKAGE 77
279 THYROID DISORDER 77
280 PROSTATE CANCER 76
281 EXTRA DOSE ADMINISTERED 75
282 INJECTION SITE DISCOLOURATION 75
283 NEPHROLITHIASIS 75
284 BLOOD THYROID STIMULATING HORMONE INCREASED 74
285 DRUG PRESCRIBING ERROR 74
286 EYE SWELLING 74
287 HYPOACUSIS 74
288 PRODUCT PRESCRIBING ISSUE 74
289 VISUAL ACUITY REDUCED 74
290 AUTISM SPECTRUM DISORDER 73
291 COGNITIVE DISORDER 73
292 HEAD INJURY 73
293 HEPATIC CIRRHOSIS 73
294 MOOD SWINGS 73
295 OBESITY 73
296 SUICIDAL IDEATION 73
297 EATING DISORDER 72
298 HYPONATRAEMIA 71
299 PRODUCT CONTAMINATION PHYSICAL 71
300 BLOOD GROWTH HORMONE DECREASED 70
301 EYE DISORDER 69
302 HYPOPITUITARISM 69
303 WRONG DOSE 69
304 CATARACT 68
305 TYPE 1 DIABETES MELLITUS 68
306 ADRENAL INSUFFICIENCY 67
307 DISEASE PROGRESSION 67
308 DRUG-INDUCED LIVER INJURY 67
309 GLUCOSE TOLERANCE IMPAIRED 67
310 MOBILITY DECREASED 67
311 CHRONIC KIDNEY DISEASE 66
312 DIABETES INSIPIDUS 66
313 HYPERGLYCAEMIA 66
314 PALLOR 66
315 BLOOD POTASSIUM DECREASED 65
316 BLOOD SODIUM DECREASED 65
317 DRUG DISPENSING ERROR 65
318 LIMB INJURY 64
319 TONSILLAR HYPERTROPHY 64
320 BLOOD TEST ABNORMAL 63
321 INJECTION SITE HAEMATOMA 63
322 LABORATORY TEST ABNORMAL 63
323 OSTEOPOROSIS 63
324 SKIN DISCOLOURATION 63
325 BONE DISORDER 62
326 DRUG INTOLERANCE 61
327 HEPATOTOXICITY 61
328 NASAL CONGESTION 61
329 SCREAMING 61
330 TONSILLAR DISORDER 61
331 TYPE 2 DIABETES MELLITUS 61
332 BONE DENSITY DECREASED 60
333 CHILLS 60
334 IDIOPATHIC INTRACRANIAL HYPERTENSION 60
335 ACCIDENT 59
336 APPENDICITIS 59
337 BONE DENSITY INCREASED 59
338 BREAST CANCER 59
339 DRUG EFFECT INCOMPLETE 59
340 INJURY 59
341 THROMBOSIS 59
342 VERTIGO 59
343 BLOOD CREATININE INCREASED 58
344 BLOOD GLUCOSE ABNORMAL 58
345 EYE PAIN 58
346 PRODUCT SUPPLY ISSUE 58
347 SPEECH DISORDER 58
348 TRANSIENT ISCHAEMIC ATTACK 58
349 WHITE BLOOD CELL COUNT DECREASED 58
350 HOT FLUSH 57
351 INJECTION SITE URTICARIA 57
352 OXYGEN SATURATION DECREASED 57
353 RENAL IMPAIRMENT 57
354 ACUTE KIDNEY INJURY 56
355 APNOEA 56
356 GROWTH HORMONE DEFICIENCY 56
357 OSTEOARTHRITIS 56
358 PITUITARY TUMOUR RECURRENT 56
359 PRODUCT CONTAMINATION 56
360 SKIN DISORDER 56
361 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 55
362 BRAIN INJURY 55
363 CARDIAC FAILURE 55
364 DRUG ADMINISTRATION ERROR 55
365 HEPATIC ENCEPHALOPATHY 55
366 HEPATIC NECROSIS 55
367 HYDROCEPHALUS 55
368 MATERNAL EXPOSURE DURING PREGNANCY 55
369 BLOOD TESTOSTERONE DECREASED 54
370 DEVICE CHEMICAL PROPERTY ISSUE 54
371 ILL-DEFINED DISORDER 54
372 MUSCULOSKELETAL PAIN 54
373 PATIENT-DEVICE INCOMPATIBILITY 54
374 PRODUCT CONTAINER ISSUE 54
375 THERAPY CHANGE 54
376 INCORRECT ROUTE OF DRUG ADMINISTRATION 53
377 LACK OF INJECTION SITE ROTATION 53
378 POLLAKIURIA 53
379 TONSILLITIS 53
380 ABORTION SPONTANEOUS 52
381 FEMUR FRACTURE 52
382 LYMPHADENOPATHY 52
383 NERVOUS SYSTEM DISORDER 52
384 PSYCHOMOTOR HYPERACTIVITY 52
385 THIRST 52
386 BLOOD UREA NITROGEN/CREATININE RATIO INCREASED 51
387 HIGH DENSITY LIPOPROTEIN DECREASED 51
388 INJECTION SITE INJURY 51
389 CHEST DISCOMFORT 50
390 INJECTION SITE VESICLES 50
391 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 50
392 PRODUCT LABEL CONFUSION 50
393 UPPER RESPIRATORY TRACT INFECTION 50
394 BLOOD PRESSURE DECREASED 49
395 CARDIAC ARREST 49
396 EPIPHYSES PREMATURE FUSION 49
397 RESPIRATORY TRACT INFECTION 49
398 VITAMIN D DEFICIENCY 49
399 DYSPHONIA 48
400 LOW DENSITY LIPOPROTEIN INCREASED 48
401 RESPIRATORY DISORDER 48
402 UNEVALUABLE EVENT 48
403 ADVERSE DRUG REACTION 47
404 EMOTIONAL DISTRESS 47
405 GROWTH FAILURE 47
406 INCORRECT PRODUCT STORAGE 47
407 PLATELET COUNT DECREASED 47
408 PRODUCT SUBSTITUTION ISSUE 47
409 ADVERSE EVENT 46
410 CEREBRAL HAEMORRHAGE 46
411 CHOLELITHIASIS 46
412 FOOT FRACTURE 46
413 FRACTURE 46
414 GASTROOESOPHAGEAL REFLUX DISEASE 46
415 HAIR GROWTH ABNORMAL 46
416 HEPATIC ENZYME INCREASED 46
417 INFLAMMATION 46
418 TINNITUS 46
419 ANKLE FRACTURE 45
420 DEAFNESS 45
421 PULMONARY EMBOLISM 45
422 BALANCE DISORDER 44
423 GYNAECOMASTIA 44
424 JOINT STIFFNESS 44
425 STAPHYLOCOCCAL INFECTION 44
426 BLOOD BILIRUBIN INCREASED 43
427 BLOOD UREA INCREASED 43
428 ENURESIS 43
429 HAEMATOCRIT DECREASED 43
430 HYPERTHYROIDISM 43
431 JOINT INJURY 43
432 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 43
433 RED BLOOD CELL COUNT DECREASED 43
434 ATRIAL FIBRILLATION 42
435 BLISTER 42
436 BRAIN OEDEMA 42
437 OBSTRUCTIVE SLEEP APNOEA SYNDROME 42
438 PANCREATITIS 42
439 PRODUCT ADMINISTRATION INTERRUPTED 42
440 RESPIRATORY FAILURE 42
441 THROMBOCYTOPENIA 42
442 WRIST FRACTURE 42
443 DEVICE USE CONFUSION 41
444 DRUG WITHDRAWAL SYNDROME 41
445 HYPERPHAGIA 41
446 MALIGNANT MELANOMA 41
447 PHARYNGITIS STREPTOCOCCAL 41
448 WEIGHT FLUCTUATION 41
449 CELLULITIS 40
450 DYSPHAGIA 40
451 MASS 40
452 NEPHROTIC SYNDROME 40
453 POOR QUALITY SLEEP 40
454 POST PROCEDURAL COMPLICATION 40
455 PRODUCT COMPLAINT 40
456 WEIGHT GAIN POOR 40
457 BLOOD CALCIUM INCREASED 39
458 CONCUSSION 39
459 DRUG EFFECT LESS THAN EXPECTED 39
460 ENERGY INCREASED 39
461 POOR QUALITY DRUG ADMINISTERED 39
462 PRECOCIOUS PUBERTY 39
463 RHABDOMYOLYSIS 39
464 BLOOD SODIUM INCREASED 38
465 BLOOD TESTOSTERONE INCREASED 38
466 GASTRIC DISORDER 38
467 GASTROINTESTINAL INFECTION 38
468 GROWING PAINS 38
469 INCORRECT DRUG ADMINISTRATION RATE 38
470 LEUKAEMIA 38
471 LIMB DISCOMFORT 38
472 OTITIS MEDIA 38
473 PRE-EXISTING CONDITION IMPROVED 38
474 PULMONARY HYPERTENSION 38
475 THYROXINE FREE DECREASED 38
476 ACROMEGALY 37
477 ARNOLD-CHIARI MALFORMATION 37
478 BENIGN INTRACRANIAL HYPERTENSION 37
479 BLOOD GROWTH HORMONE INCREASED 37
480 COMA 37
481 CYST 37
482 DEPRESSED LEVEL OF CONSCIOUSNESS 37
483 GAIT INABILITY 37
484 JOINT DISLOCATION 37
485 PRODUCT DISPENSING ISSUE 37
486 RED CELL DISTRIBUTION WIDTH INCREASED 37
487 SCRATCH 37
488 WITHDRAWAL SYNDROME 37
489 ARRHYTHMIA 36
490 FLATULENCE 36
491 FLUSHING 36
492 LUNG DISORDER 36
493 LYMPHOMA 36
494 NEUROPATHY PERIPHERAL 36
495 PRODUCT DISTRIBUTION ISSUE 36
496 STRABISMUS 36
497 CORONARY ARTERY DISEASE 35
498 DEMENTIA 35
499 DYSGEUSIA 35
500 FOOT DEFORMITY 35
501 HALLUCINATION 35
502 HIP FRACTURE 35
503 IMMUNE SYSTEM DISORDER 35
504 PRODUCT LABEL ISSUE 35
505 PRODUCT PHYSICAL CONSISTENCY ISSUE 35
506 REACTION TO PRESERVATIVES 35
507 RENAL TRANSPLANT 35
508 SKIN LESION 35
509 STEVENS-JOHNSON SYNDROME 35
510 THYROXINE INCREASED 35
511 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 34
512 CARDIAC FAILURE CONGESTIVE 34
513 DRY MOUTH 34
514 DYSPEPSIA 34
515 HAEMATOCRIT INCREASED 34
516 KNEE DEFORMITY 34
517 NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL INCREASED 34
518 PATIENT-DEVICE INTERACTION ISSUE 34
519 SKIN ODOUR ABNORMAL 34
520 TIBIA FRACTURE 34
521 UNRESPONSIVE TO STIMULI 34
522 DEVICE DEPOSIT ISSUE 33
523 DIABETIC KETOACIDOSIS 33
524 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 33
525 EAR PAIN 33
526 EOSINOPHIL COUNT INCREASED 33
527 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 33
528 GASTRITIS 33
529 HUNGER 33
530 APPLICATION SITE PAIN 32
531 ASTROCYTOMA 32
532 BLOOD PROLACTIN INCREASED 32
533 DEVICE CALIBRATION FAILURE 32
534 DIPLOPIA 32
535 DOSE CALCULATION ERROR 32
536 DRUG DELIVERY SYSTEM ISSUE 32
537 HAEMATOCHEZIA 32
538 HAEMOGLOBIN INCREASED 32
539 HAND FRACTURE 32
540 HYPOPHAGIA 32
541 MELANOCYTIC NAEVUS 32
542 MUSCLE ATROPHY 32
543 NEUTROPENIA 32
544 SPINAL DISORDER 32
545 URINARY INCONTINENCE 32
546 ADRENAL DISORDER 31
547 AIR IN DEVICE ISSUE 31
548 BREAST PAIN 31
549 CEREBRAL DISORDER 31
550 CROHN^S DISEASE 31
551 DENGUE FEVER 31
552 ECZEMA 31
553 GERM CELL CANCER 31
554 HYPERTROPHIC CARDIOMYOPATHY 31
555 INSULIN RESISTANCE 31
556 INTERVERTEBRAL DISC PROTRUSION 31
557 MENTAL IMPAIRMENT 31
558 PRESYNCOPE 31
559 RASH PRURITIC 31
560 THERAPEUTIC RESPONSE DECREASED 31
561 AFFECTIVE DISORDER 30
562 ANAPHYLACTIC REACTION 30
563 BLOOD INSULIN INCREASED 30
564 COELIAC DISEASE 30
565 DIABETES MELLITUS INADEQUATE CONTROL 30
566 FAILURE TO THRIVE 30
567 FEELING COLD 30
568 KIDNEY INFECTION 30
569 MUSCULOSKELETAL DISORDER 30
570 PANIC ATTACK 30
571 PRODUCT COLOUR ISSUE 30
572 PROTEINURIA 30
573 THERAPEUTIC PRODUCT EFFECT DECREASED 30
574 WHEEZING 30
575 BACK DISORDER 29
576 BEHAVIOUR DISORDER 29
577 BODY HEIGHT DECREASED 29
578 ELECTROLYTE IMBALANCE 29
579 INTENTIONAL SELF-INJURY 29
580 LYMPHOCYTE COUNT DECREASED 29
581 MEAN CELL HAEMOGLOBIN DECREASED 29
582 MUSCULOSKELETAL DISCOMFORT 29
583 NIGHT SWEATS 29
584 PRODUCT PACKAGING ISSUE 29
585 SUDDEN DEATH 29
586 THROAT TIGHTNESS 29
587 BASAL CELL CARCINOMA 28
588 CARDIOVASCULAR DISORDER 28
589 COLON CANCER 28
590 FACE OEDEMA 28
591 GLOMERULAR FILTRATION RATE DECREASED 28
592 GROWTH DISORDER 28
593 HAEMATOMA 28
594 HYPERNATRAEMIA 28
595 LIGAMENT SPRAIN 28
596 LYMPHOCYTE COUNT INCREASED 28
597 NIGHTMARE 28
598 PLATELET COUNT INCREASED 28
599 PLEURAL EFFUSION 28
600 RED BLOOD CELL COUNT INCREASED 28
601 SUICIDE ATTEMPT 28
602 ANGINA PECTORIS 27
603 CRANIOCEREBRAL INJURY 27
604 DIVERTICULITIS 27
605 ENDOCRINE DISORDER 27
606 GALLBLADDER DISORDER 27
607 IMPAIRED HEALING 27
608 INITIAL INSOMNIA 27
609 LIVER DISORDER 27
610 MENINGITIS 27
611 OSTEOPENIA 27
612 PSYCHOTIC DISORDER 27
613 RASH GENERALISED 27
614 THYROID CANCER 27
615 WHITE BLOOD CELL COUNT INCREASED 27
616 BLOOD CALCIUM DECREASED 26
617 BLOOD URINE PRESENT 26
618 BODY TEMPERATURE INCREASED 26
619 BRAIN NEOPLASM MALIGNANT 26
620 CEREBRAL CYST 26
621 DISORIENTATION 26
622 FEAR 26
623 HAEMATURIA 26
624 HEPATOMEGALY 26
625 HERNIA 26
626 INJECTION SITE INDURATION 26
627 LIMB DEFORMITY 26
628 OBSTRUCTIVE AIRWAYS DISORDER 26
629 PRODUCT STORAGE ISSUE 26
630 RECURRENT CANCER 26
631 SKIN EXFOLIATION 26
632 TIC 26
633 WRONG TECHNIQUE IN DRUG USAGE PROCESS 26
634 ANGIOEDEMA 25
635 ANION GAP INCREASED 25
636 BLOOD CREATINE PHOSPHOKINASE INCREASED 25
637 BLOOD FOLLICLE STIMULATING HORMONE INCREASED 25
638 BLOOD PARATHYROID HORMONE INCREASED 25
639 COLITIS ULCERATIVE 25
640 DEVICE LOOSENING 25
641 FIBROMYALGIA 25
642 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 25
643 INCORRECT PRODUCT ADMINISTRATION DURATION 25
644 INTESTINAL OBSTRUCTION 25
645 MEDULLOBLASTOMA 25
646 MIDDLE INSOMNIA 25
647 MUSCLE DISORDER 25
648 PANCREATITIS ACUTE 25
649 PRODUCT TEMPERATURE EXCURSION ISSUE 25
650 RESPIRATORY DISTRESS 25
651 SUBARACHNOID HAEMORRHAGE 25
652 THERAPY NON-RESPONDER 25
653 ACUTE MYOCARDIAL INFARCTION 24
654 ASTHMATIC CRISIS 24
655 CARDIO-RESPIRATORY ARREST 24
656 CARDIOMYOPATHY 24
657 CIRCULATORY COLLAPSE 24
658 DRUG LEVEL INCREASED 24
659 DYSARTHRIA 24
660 EAR DISORDER 24
661 GASTROINTESTINAL HAEMORRHAGE 24
662 HEAD DISCOMFORT 24
663 HIP SURGERY 24
664 HUMERUS FRACTURE 24
665 INADVERTENT INJECTION AIR BUBBLE 24
666 INSURANCE ISSUE 24
667 LIPODYSTROPHY ACQUIRED 24
668 METABOLIC DISORDER 24
669 MONOCYTE COUNT INCREASED 24
670 RESPIRATORY ARREST 24
671 SKIN HAEMORRHAGE 24
672 SKIN LACERATION 24
673 URINARY RETENTION 24
674 VIITH NERVE PARALYSIS 24
675 BLOOD CHLORIDE INCREASED 23
676 BLOOD IRON DECREASED 23
677 BLOOD POTASSIUM INCREASED 23
678 CONJUNCTIVITIS 23
679 CORTISOL DECREASED 23
680 DYSKINESIA 23
681 DYSURIA 23
682 HEMIPARESIS 23
683 HEPATIC STEATOSIS 23
684 HEPATITIS 23
685 HIP ARTHROPLASTY 23
686 IMMUNODEFICIENCY 23
687 INJECTION SITE NODULE 23
688 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 23
689 NEUTROPHIL COUNT DECREASED 23
690 NEUTROPHIL COUNT INCREASED 23
691 PERSONALITY CHANGE 23
692 PNEUMONIA ASPIRATION 23
693 RIB FRACTURE 23
694 TENDON RUPTURE 23
695 UNDERWEIGHT 23
696 BLOOD ALBUMIN INCREASED 22
697 CARBON DIOXIDE DECREASED 22
698 CARDIAC OPERATION 22
699 ERECTILE DYSFUNCTION 22
700 GROWTH ACCELERATED 22
701 HYPOKALAEMIA 22
702 HYPOXIA 22
703 ISCHAEMIC STROKE 22
704 KNEE ARTHROPLASTY 22
705 LACRIMATION INCREASED 22
706 MYOSITIS 22
707 OSTEOCHONDROMA 22
708 OVARIAN CYST 22
709 PETIT MAL EPILEPSY 22
710 PHOTOPHOBIA 22
711 PRODUCTIVE COUGH 22
712 RASH ERYTHEMATOUS 22
713 SLUGGISHNESS 22
714 SPINAL OPERATION 22
715 THYROXINE FREE INCREASED 22
716 TRANSAMINASES INCREASED 22
717 ADENOIDECTOMY 21
718 APATHY 21
719 BLOOD UREA DECREASED 21
720 BRADYCARDIA 21
721 C-REACTIVE PROTEIN INCREASED 21
722 DEVICE RELATED INFECTION 21
723 DRUG DEPENDENCE 21
724 FAECES DISCOLOURED 21
725 HERPES ZOSTER 21
726 INABILITY TO AFFORD MEDICATION 21
727 LARYNGITIS 21
728 LIP SWELLING 21
729 MEDULLOBLASTOMA RECURRENT 21
730 NOCTURIA 21
731 OCULAR HYPERAEMIA 21
732 OVERWEIGHT 21
733 PERIPHERAL COLDNESS 21
734 PERITONITIS 21
735 POLYCYTHAEMIA 21
736 POLYURIA 21
737 PRODUCT SUBSTITUTION 21
738 RESPIRATORY SYNCYTIAL VIRUS INFECTION 21
739 RESTLESSNESS 21
740 RHEUMATOID ARTHRITIS 21
741 SEASONAL ALLERGY 21
742 SNEEZING 21
743 SYSTEMIC LUPUS ERYTHEMATOSUS 21
744 TENSION 21
745 BLOOD GLUCOSE FLUCTUATION 20
746 BRAIN FOG 20
747 BREAST MASS 20
748 BRONCHOSPASM 20
749 COLITIS 20
750 CREUTZFELDT-JAKOB DISEASE 20
751 CYSTITIS 20
752 DEVICE BATTERY ISSUE 20
753 DEVICE INFUSION ISSUE 20
754 DRUG EFFECT DECREASED 20
755 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 20
756 DYSSTASIA 20
757 FOETAL EXPOSURE DURING PREGNANCY 20
758 GLIOMA 20
759 GROIN PAIN 20
760 HYPERCALCAEMIA 20
761 HYPOTONIA 20
762 INGUINAL HERNIA 20
763 IRRITABLE BOWEL SYNDROME 20
764 LOCALISED INFECTION 20
765 LUNG NEOPLASM MALIGNANT 20
766 MEAN CELL VOLUME DECREASED 20
767 METABOLIC ACIDOSIS 20
768 PARALYSIS 20
769 PRODUCT EXPIRATION DATE ISSUE 20
770 PULMONARY OEDEMA 20
771 RASH MACULAR 20
772 SEPTIC SHOCK 20
773 SINUS DISORDER 20
774 SPINAL DEFORMITY 20
775 TEMPERATURE INTOLERANCE 20
776 TENDONITIS 20
777 THYROXINE DECREASED 20
778 WRONG PATIENT RECEIVED MEDICATION 20
779 ACUTE MYELOID LEUKAEMIA 19
780 APPETITE DISORDER 19
781 ATTENTION DEFICIT HYPERACTIVITY DISORDER 19
782 BLOOD DISORDER 19
783 CEREBRAL INFARCTION 19
784 DERMATITIS ATOPIC 19
785 DEVELOPMENTAL DELAY 19
786 DEVICE DISLOCATION 19
787 EXOSTOSIS 19
788 FOOD ALLERGY 19
789 GENERALISED OEDEMA 19
790 GLAUCOMA 19
791 GLIONEURONAL TUMOUR 19
792 GOITRE 19
793 HYPERTRICHOSIS 19
794 INJECTION SITE IRRITATION 19
795 INTRAOCULAR PRESSURE INCREASED 19
796 JUVENILE IDIOPATHIC ARTHRITIS 19
797 KNEE OPERATION 19
798 MEDICAL DEVICE COMPLICATION 19
799 MUSCLE TIGHTNESS 19
800 MUSCLE TWITCHING 19
801 OESOPHAGEAL DISORDER 19
802 OSTEOMYELITIS 19
803 PRURITUS GENERALISED 19
804 RECTAL HAEMORRHAGE 19
805 SCAR 19
806 SHOCK 19
807 TONSILLECTOMY 19
808 TOOTH DISORDER 19
809 VARICOSE VEIN 19
810 VENTRICULAR HYPERTROPHY 19
811 VISUAL FIELD DEFECT 19
812 ACCIDENTAL UNDERDOSE 18
813 ADENOIDAL DISORDER 18
814 BLOOD GROWTH HORMONE ABNORMAL 18
815 BONE DEVELOPMENT ABNORMAL 18
816 DEVELOPMENTAL HIP DYSPLASIA 18
817 ELECTRIC SHOCK SENSATION 18
818 ENCEPHALOPATHY 18
819 FEBRILE CONVULSION 18
820 FRUSTRATION TOLERANCE DECREASED 18
821 GENERALISED TONIC-CLONIC SEIZURE 18
822 INJECTION SITE ATROPHY 18
823 INJECTION SITE SCAR 18
824 KIDNEY TRANSPLANT REJECTION 18
825 LIPOMA 18
826 MEAN CELL VOLUME INCREASED 18
827 MOVEMENT DISORDER 18
828 MULTIPLE SCLEROSIS 18
829 NEURALGIA 18
830 PHARYNGITIS 18
831 PNEUMOTHORAX 18
832 POLYDIPSIA 18
833 PROTEIN-LOSING GASTROENTEROPATHY 18
834 PSORIASIS 18
835 RASH PAPULAR 18
836 SEPTO-OPTIC DYSPLASIA 18
837 STOMATITIS 18
838 ABASIA 17
839 ADDISON^S DISEASE 17
840 ANAPHYLACTIC SHOCK 17
841 ANGIOPATHY 17
842 ANHEDONIA 17
843 AUTOIMMUNE THYROIDITIS 17
844 BLINDNESS UNILATERAL 17
845 BLOOD ALBUMIN DECREASED 17
846 BLOOD ALKALINE PHOSPHATASE DECREASED 17
847 BLOOD PHOSPHORUS INCREASED 17
848 BLOOD PRESSURE ABNORMAL 17
849 BRAIN OPERATION 17
850 CARDIOMEGALY 17
851 CRYPTORCHISM 17
852 CYANOSIS 17
853 DEMENTIA ALZHEIMER^S TYPE 17
854 DIZZINESS POSTURAL 17
855 EYE IRRITATION 17
856 HAEMATEMESIS 17
857 HYPERLIPIDAEMIA 17
858 HYPOGLYCAEMIC SEIZURE 17
859 INFECTIOUS MONONUCLEOSIS 17
860 INJECTION SITE INFLAMMATION 17
861 LEUKOPENIA 17
862 LIMB ASYMMETRY 17
863 OBSESSIVE-COMPULSIVE DISORDER 17
864 PARTIAL SEIZURES 17
865 PRODUCT FORMULATION ISSUE 17
866 SPLENOMEGALY 17
867 SYRINGOMYELIA 17
868 THYROID NEOPLASM 17
869 ATRIOVENTRICULAR BLOCK COMPLETE 16
870 BLOOD CHLORIDE DECREASED 16
871 BREAST ENLARGEMENT 16
872 BREAST SWELLING 16
873 CONTRAINDICATED PRODUCT ADMINISTERED 16
874 DELAYED PUBERTY 16
875 DRUG DELIVERY SYSTEM MALFUNCTION 16
876 FEEDING DISORDER 16
877 GLIOBLASTOMA 16
878 GRAND MAL CONVULSION 16
879 HAEMORRHAGE INTRACRANIAL 16
880 HEART RATE DECREASED 16
881 HEPATOBLASTOMA 16
882 INJECTION SITE PARAESTHESIA 16
883 INTENTIONAL DEVICE USE ISSUE 16
884 INTENTIONAL OVERDOSE 16
885 JAW DISORDER 16
886 LEFT VENTRICULAR HYPERTROPHY 16
887 LIGAMENT RUPTURE 16
888 LIMB OPERATION 16
889 MALNUTRITION 16
890 MALOCCLUSION 16
891 MENSTRUATION IRREGULAR 16
892 NERVE COMPRESSION 16
893 OSTEOSARCOMA 16
894 PAPILLARY THYROID CANCER 16
895 PHAEOCHROMOCYTOMA 16
896 PIGMENTATION DISORDER 16
897 PRODUCT DELIVERY MECHANISM ISSUE 16
898 RECALLED PRODUCT ADMINISTERED 16
899 SKIN CANCER 16
900 SKIN STRIAE 16
901 SUSPECTED COUNTERFEIT PRODUCT 16
902 THROAT IRRITATION 16
903 VASCULITIS 16
904 WOUND COMPLICATION 16
905 WRONG PRODUCT ADMINISTERED 16
906 ABSCESS 15
907 ACUTE LYMPHOCYTIC LEUKAEMIA 15
908 AORTIC VALVE DISEASE 15
909 APPENDIX DISORDER 15
910 BACTERIAL INFECTION 15
911 BLADDER CANCER 15
912 BLOOD CORTICOTROPHIN DECREASED 15
913 DEEP VEIN THROMBOSIS 15
914 DEVICE USER INTERFACE ISSUE 15
915 EXPOSURE DURING PREGNANCY 15
916 EYE HAEMORRHAGE 15
917 GASTRIC HAEMORRHAGE 15
918 IMPAIRED GASTRIC EMPTYING 15
919 IMPULSIVE BEHAVIOUR 15
920 INTERCEPTED PRODUCT SELECTION ERROR 15
921 LIBIDO DECREASED 15
922 MENOPAUSE 15
923 OCULAR DISCOMFORT 15
924 OFF LABEL USE OF DEVICE 15
925 PITUITARY CYST 15
926 PYELONEPHRITIS 15
927 RETCHING 15
928 ROTATOR CUFF SYNDROME 15
929 SENSORY DISTURBANCE 15
930 SKIN REACTION 15
931 STREPTOCOCCAL INFECTION 15
932 THYROID FUNCTION TEST ABNORMAL 15
933 UMBILICAL HERNIA 15
934 ADMINISTRATION SITE PAIN 14
935 AGEUSIA 14
936 AORTIC ANEURYSM 14
937 AUTOIMMUNE DISORDER 14
938 BLOOD CORTISOL DECREASED 14
939 BLOOD FOLLICLE STIMULATING HORMONE DECREASED 14
940 CEREBRAL SALT-WASTING SYNDROME 14
941 CORTISOL INCREASED 14
942 DEAFNESS UNILATERAL 14
943 DEVICE MATERIAL OPACIFICATION 14
944 DIALYSIS 14
945 DISABILITY 14
946 DRUG LEVEL DECREASED 14
947 ECONOMIC PROBLEM 14
948 EDUCATIONAL PROBLEM 14
949 EXPOSURE VIA EYE CONTACT 14
950 FOCAL NODULAR HYPERPLASIA 14
951 HEPATIC FUNCTION ABNORMAL 14
952 HEPATIC NEOPLASM 14
953 HYPONATRAEMIC SEIZURE 14
954 INTERCEPTED PRODUCT ADMINISTRATION ERROR 14
955 INTERCEPTED PRODUCT PRESCRIBING ERROR 14
956 LACK OF ADMINISTRATION SITE ROTATION 14
957 LIVER FUNCTION TEST ABNORMAL 14
958 MEAN PLATELET VOLUME INCREASED 14
959 MULTI-ORGAN FAILURE 14
960 MYOPIA 14
961 NEUROFIBROMATOSIS 14
962 NO THERAPEUTIC RESPONSE 14
963 PARKINSON^S DISEASE 14
964 PERIORBITAL SWELLING 14
965 PITUITARY-DEPENDENT CUSHING^S SYNDROME 14
966 PRIMARY HYPOTHYROIDISM 14
967 PRODUCT CONTAMINATION WITH BODY FLUID 14
968 PROSTATIC DISORDER 14
969 PULMONARY FIBROSIS 14
970 QUALITY OF LIFE DECREASED 14
971 RENAL FAILURE ACUTE 14
972 RHINITIS 14
973 RHINOVIRUS INFECTION 14
974 SARS-COV-2 TEST POSITIVE 14
975 STRESS FRACTURE 14
976 TOOTH LOSS 14
977 TREATMENT FAILURE 14
978 TYMPANIC MEMBRANE PERFORATION 14
979 VARICELLA 14
980 ALBUMIN GLOBULIN RATIO INCREASED 13
981 ARTHROPOD BITE 13
982 BIPOLAR DISORDER 13
983 BLOOD IMMUNOGLOBULIN A INCREASED 13
984 BRONCHIOLITIS 13
985 CARDIAC MURMUR 13
986 CHOKING 13
987 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13
988 COAGULOPATHY 13
989 DEVICE SAFETY FEATURE ISSUE 13
990 END STAGE RENAL DISEASE 13
991 EYELID OEDEMA 13
992 GLIOBLASTOMA MULTIFORME 13
993 GLOBULINS DECREASED 13
994 HAIR TEXTURE ABNORMAL 13
995 HEART RATE IRREGULAR 13
996 HEPATIC ADENOMA 13
997 HYPERTHERMIA 13
998 HYPOPHYSITIS 13
999 HYPOTHERMIA 13